Risks and benefits of the new antiepileptic drugs;Riesgos y beneficios de los nuevos fármacos antiepilépticos

Revista de Neurologia

Volumn 42, Issue SUPPL. 3, 2006, Pages

  Campos Olazábal, Patricia ^a  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Antiepileptic drugs; Epilepsy; Social cost of epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ANOREXIA; ASTHENIA; ATAXIA; BEHAVIOR EXACERBATION; CLOSED ANGLE GLAUCOMA; COGNITIVE DEFECT; CONFERENCE PAPER; DROWSINESS; DRUG COST; DRUG ERUPTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG POTENTIATION; EPILEPSY; HUMAN; HYPERSENSITIVITY REACTION; METABOLIC ACIDOSIS; MYOCLONUS; NAUSEA; NEPHROLITHIASIS; PEDIATRICS; SEDATION; SIDE EFFECT; TREMOR; UNSPECIFIED SIDE EFFECT; VERTIGO; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION;

ANTICONVULSANTS; CHILD; EPILEPSY; HUMANS; RISK;

EID: 34548751158     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Sullivan JE, Dlugos DJ. Antiepileptic drug monotherapy: pediatric concerns. In Jong M, ed. Seminars in Pediatric Neurology. London: Elsevier; 2005. p. 88-96.
2. Nieto-Barrera M, Brozmanova M, Capovilla G. A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res 2001; 46: 145-55.
3. Privitera MD, Brodie MJ, Mattson RH. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 2003; 107: 165-75.
4. Coppola G, Auricchio G, Federico R. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. Epilepsia 2004; 45: 1049-53.
5. Arroyo S, Asconapé J. Nuevos fármacos antiepilé pticos. In Campos M, Kanner A, eds. Epilepsias, diagnóstico y tratamiento. Santiago de Chile: Mediterráneo; 2004. p. 470-87.
6. Arroyo S, Wang S, Twyman R. Topiramate: effective as monotherapy in dose-response study in newly diagnosed epilepsy. Epilepsia 2002; 43 (Suppl 7): S241 [abstract].
7. Grupo de Estudio de la Epilepsia. Guía oficial para el diagnóstico y tratamiento de la epilepsia. Madrid: SEN; 2004.
8. Silva-Sieger FA, García-Gómez RG. Aspectos económicos. In Medina C, ed. Epilepsia, aspectos clínicos y psicosociales. 1 ed. Bogotá: Panamericana; 2004. p. 487-95.